Bart L Clarke MD
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid
Professor of Medicine
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Clarke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1986 - 1989
David Geffen School of Medicine at UCLAClass of 1986
Certifications & Licensure
MN State Medical License 1987 - 2027
IA State Medical License 1998 - 2006
IL State Medical License 1994 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Patient Lists, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
Clinical Trials
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
- A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism Start of enrollment: 2020 Jul 23
Publications & Presentations
PubMed
- Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial.Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, Aliya Khan, Peter Schwarz
Journal of Bone and Mineral Research. 2026-02-04 - 4 citationsIncreased Risk of Cardiovascular Diseases in Patients With Chronic Hypoparathyroidism in Sweden.Sigridur Björnsdottir, Michael Mannstadt, Bart Clarke, Tim Spelman, Olle Kämpe
The Journal of Clinical Endocrinology and Metabolism. 2025-11-18 - Response to Letter to the Editor From Hasebe and Su: "Higher Risk of Cardiovascular Diseases in Patients With Chronic Hypoparathyroidism in Sweden".Sigridur Björnsdottir, Michael Mannstadt, Bart Clarke, Tim Spelman
The Journal of Clinical Endocrinology and Metabolism. 2025-11-18
Lectures
- Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 InhibitorENDO 2019 - New Orleans, LA - 3/25/2019
- PTH Replacement Therapy in Hypoparathyroidism: When and How to ProceedENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
- Opening Comments: 2018 Parathyroid Summit: A Focus on HypoparathyroidismENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Press Mentions
Sustained Benefits with TransCon PTH in HypoparathyroidismNovember 18th, 2024- Parathyroid Hormone Therapy Normalizes Calcium for Most with HypoparathyroidismOctober 15th, 2024
- Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR SaysSeptember 22nd, 2022
Committees
- Co-Chair, ASBMR Development Committee 2014 - Present
- Member, ASBMR Council 2013 - Present
- Member, The Endocrine Society Development Committee 2009 - Present
- Member, FDA Advisory Committee on Reproductive Health Drugs 2010 - 2013
Professional Memberships
- Fellow
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
